HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrence of Pneumocystis carinii pneumonia in an HIV-infected patient: apparent selective immune reconstitution after initiation of antiretroviral therapy.

Abstract
Although several studies have reported that it is safe to discontinue secondary Pneumocystis carinii pneumonia (PCP) prophylaxis in patients infected with HIV who experience a sustained immune response as a result of antiretroviral therapy, we describe a patient who developed recurrent PCP <3 months after discontinuing trimethoprim-sulfamethoxazole prophylaxis. He developed disease despite a sustained CD4 T-cell count above 200 cells/microL for more than 3 years while on antiretroviral therapy, as well as an apparent immune reconstitution against disseminated Mycobacterium avium complex (MAC) and Histoplasma capsulatum, for which he also discontinued therapy but without adverse effects. Thus, although increasing evidence continues to indicate that HIV-infected patients receiving combinations of antiretroviral therapies may regain specific immunity against opportunistic infections, our patient's experience suggests that this immune recovery may be selective and incomplete.
AuthorsK Crothers, L Huang
JournalHIV medicine (HIV Med) Vol. 4 Issue 4 Pg. 346-9 (Oct 2003) ISSN: 1464-2662 [Print] England
PMID14525547 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination
Topics
  • AIDS-Related Opportunistic Infections (complications, drug therapy, immunology)
  • Adult
  • Anti-Infective Agents (therapeutic use)
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Humans
  • Male
  • Pneumonia, Pneumocystis (complications, drug therapy, immunology)
  • Secondary Prevention
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: